ABSTRACT The increasing prevalence of variant lineages during the COVID-19 pandemic has the potential to disrupt molecular diagnostics due to mismatches between primers and variant templates. Point-of-care molecular diagnostics. which often lack the complete functionality of their high-throughput laboratory counterparts. are particularly susceptible to this type of disruption. https://www.chiggate.com/grahams-natural-c-eczema-dermatitis-relief-cream-120g-supply/